计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| U413771-5mg |
5mg |
现货 ![]() |
| |
| U413771-10mg |
10mg |
现货 ![]() |
| |
| U413771-25mg |
25mg |
期货 ![]() |
| |
| U413771-50mg |
50mg |
现货 ![]() |
| |
| U413771-100mg |
100mg |
现货 ![]() |
|
| 英文别名 | 2-[4-[(4-bromophenyl)sulfonylamino]-1-hydroxynaphthalen-2-yl]sulfanylacetic acid | UMI 77 |
|---|---|
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | UMI-77 |
| 生化机理 | UMI-77 是一种选择性 Mcl-1 抑制剂,Ki 为 490 nM,对 Bcl-2 家族的其他成员具有选择性。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
Information UMI-77 UMI-77 is a selective Mcl-1 inhibitor with Ki of 490 nM, showing selectivity over other members of Bcl-2 family. Targets Mcl-1 (Cell-free assay) 490 nM(Ki) In vitro UMI-77 effectively disrupts the interactions between BL-Noxa and cellular Mcl-1, as well as Mcl-1/Bax protein–protein interactions. UMI-77 inhibits growth of pancreatic cancer cells with IC50 of 3.4, 4.4, 12.5, 16.1, and 5.5 μM for BxPC-3, Panc-1, MiaPaCa-2, AsPC-1 and Capan-2 cells, respectively. UMI-77 induced apoptosis in pancreatic cancer through activation of the intrinsic apoptotic pathway and/or Bax conformational change. In vivo In a BxPC-3 xenograft mouse model, UMI-77 (60 mg/kg i.v.) exhibits single-agent antitumor activity without any damage normal tissues. Cell Research(from reference) Cell lines:Human pancreatic cancer cell lines AsPC-1, BxPC-3, Panc-1, MiaPaCa and Capan-2 Concentrations:~100 μM Incubation Time:4 days |
| 纯度 | ≥98% |
| ALogP | 3.755 |
|---|---|
| HBD Count | 2 |
| Rotatable Bond | 6 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 504760359 |
|---|---|
| 分子类型 | 小分子 |
| IIUPAC Name | 2-[4-[(4-bromophenyl)sulfonylamino]-1-hydroxynaphthalen-2-yl]sulfanylacetic acid |
| INCHI | 1S/C18H14BrNO5S2/c19-11-5-7-12(8-6-11)27(24,25)20-15-9-16(26-10-17(21)22)18(23)14-4-2-1-3-13(14)15/h1-9,20,23H,10H2,(H,21,22) |
| InChi Key | WUGANDSUVKXMEC-UHFFFAOYSA-N |
| Smiles | C1=CC=C2C(=C1)C(=CC(=C2O)SCC(=O)O)NS(=O)(=O)C3=CC=C(C=C3)Br |
| Isomeric SMILES | C1=CC=C2C(=C1)C(=CC(=C2O)SCC(=O)O)NS(=O)(=O)C3=CC=C(C=C3)Br |
| PubChem CID | 992586 |
| 分子量 | 468.34 |
| 溶解性 | Solubility (25°C) In vitro DMSO: 93 mg/mL (198.57 mM); Ethanol: 93 mg/mL warmed with 50ºC Water: bath (198.57 mM); Water: Insoluble; |
|---|---|
| DMSO(mg / mL) Max Solubility | 93 |
| DMSO(mM) Max Solubility | 198.5736858 |
| Water(mg / mL) Max Solubility | <1 |
| 分子量 | 468.300 g/mol |
| XLogP3 | 4.100 |
| 氢键供体数Hydrogen Bond Donor Count | 3 |
| 氢键受体数Hydrogen Bond Acceptor Count | 7 |
| 可旋转键计数Rotatable Bond Count | 6 |
| 精确质量Exact Mass | 466.95 Da |
| 单同位素质量Monoisotopic Mass | 466.95 Da |
| 拓扑极表面积Topological Polar Surface Area | 137.000 Ų |
| 重原子数Heavy Atom Count | 27 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 618.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS05, GHS07 |
|---|---|
| 信号词 | 危险 |
| 危险声明 |
H302: 吞食有害 H315: 引起皮肤刺激 H318: 造成严重的眼睛损伤 H335: 可能引起呼吸道刺激 |
| 预防措施声明 |
P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾 P264: 处理后要彻底洗手。 P270: 使用本产品时,请勿进食、饮水或吸烟。 P271: 仅在室外或通风良好的地方使用。 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P310: 立即致电解毒中心或医生。 P302+P352: 如皮肤沾染:用水充分清洗。 P305+P351+P338: 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 P332+P313: 如发生皮肤刺激:求医/就诊。 P405: 密闭存放 P403+P233: 存放在通风良好的地方。保持容器密闭。 P501: 将内容物/容器处理到。。。 P301+P312+P330: 如误吞咽:如感觉不适,呼叫急救中心/医生。漱口 P304+P340+P312: 如误吸入:将人转移到空气新鲜处,保持呼吸舒适体位。如感觉不适,呼叫急救中心/医生。 |
| 1. Abulwerdi F, Liao C, Liu M, Azmi AS, Aboukameel A, Mady AS, Gulappa T, Cierpicki T, Owens S, Zhang T et al.. (2014) A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo.. Mol Cancer Ther, 13 (3): (565-75). [PMID:24019208] |